Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 713 transactions and raising C$86.1 billion on behalf of our clients in fiscal 20211.2.

Filter our transactions* using the categories below:

Kingston Resources
A$13m
December 2020

Kingston Resources

Lead Manager (Placement)
METALS AND MINING EQUITY CAPITAL MARKETS AUSTRALIA
Ayr Wellness Inc.
US$110m
December 2020

Ayr Wellness Inc.

Sole Lead Bookrunner (Senior Secured Notes)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS US
Leaf Group Ltd.
US$34m
December 2020

Leaf Group Ltd.

Sole Bookrunning Manager (Follow-on)
TECHNOLOGY EQUITY CAPITAL MARKETS US
View transaction detail
Open Lending Corporation
December 2020

Open Lending Corporation

Co-Manager (Follow-on)
TECHNOLOGY EQUITY CAPITAL MARKETS US
Salt Lake Potash
A$53m
December 2020

Salt Lake Potash

Joint Lead Manager (Placement)
METALS AND MINING EQUITY CAPITAL MARKETS AUSTRALIA
Airbnb, Inc
December 2020

Airbnb, Inc

Co-Manager (IPO)
TECHNOLOGY EQUITY CAPITAL MARKETS US
TRYP Therapeutics Inc.
C$5m
December 2020

TRYP Therapeutics Inc.

Sole Lead Agent & Bookrunner (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS CANADA
The Green Organic Dutchman
C$13m
December 2020

The Green Organic Dutchman

Co-Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
C3.ai
US$749m
December 2020

C3.ai

Co-Manager (IPO)
TECHNOLOGY EQUITY CAPITAL MARKETS US
View transaction detail
WeCommerce
C$60m
December 2020

WeCommerce

Co-lead Agent (Private Placement RTO Transaction)
TECHNOLOGY EQUITY CAPITAL MARKETS CANADA
Amryt Pharma Plc
US$40m
December 2020

Amryt Pharma Plc

Co-Agent (Private Placement)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Atara Biotherapeutics
US$175m
December 2020

Atara Biotherapeutics

Lead Manager (Follow-On Offering)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail